RxSight, Inc. (RXST) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for RxSight, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -11.02x | -48.67x | -28.58x | -5.25x | -6.32x | 11.07x |
| P/B Ratio | 1.56x | 4.75x | 8.66x | 3.90x | 2.23x | -1.03x |
| P/S Ratio | 3.19x | 9.55x | 15.60x | 7.15x | 13.63x | 20.79x |
| Profitability | ||||||
| Gross Margin | 76.6% | 70.7% | 60.4% | 43.5% | 20.0% | 11.6% |
| Operating Margin | -35.8% | -26.3% | -56.2% | -129.2% | -233.6% | -241.2% |
| Net Margin | -29.0% | -19.6% | -54.6% | -136.2% | -215.5% | 187.9% |
| EBITDA Margin | -29.5% | -17.0% | -46.1% | -117.9% | -181.5% | 219.1% |
| Liquidity | ||||||
| Current Ratio | 10.95x | 11.36x | 8.06x | 7.81x | 15.92x | 7.03x |
| Quick Ratio | 9.75x | 10.50x | 7.22x | 6.95x | 15.19x | 6.31x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.04x | 0.02x | 0.50x | 0.33x | -0.10x |
YoY = year-over-year change. Source: FMP..